Clinical Pharmacokinetics of Tretinoin
- 1 May 1997
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 32 (5) , 382-402
- https://doi.org/10.2165/00003088-199732050-00004
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- TretinoinDrugs, 1995
- Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemiaThe Lancet, 1994
- Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdownThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the SkinJNCI Journal of the National Cancer Institute, 1992
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- Ligand‐specific and non‐specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP)European Journal of Clinical Investigation, 1989
- Retinoids in DermatologyMayo Clinic Proceedings, 1987
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987